Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
KLBF.JK Stock Summary
Top 10 Correlated ETFs
KLBF.JK
In the News
KLBF.JK Financial details
Company Rating
Buy
Market Cap
73777.68B
Income
2961.62B
Revenue
30312.74B
Book val./share
-
Cash/share
-
Dividend
38
Dividend %
2.37%
Employees
13.17K
Optionable
No
Shortable
Yes
Earnings
31 Oct 2023
P/E
25.21
Forward P/E
18.85
PEG
-10.83
P/S
2.45
P/B
3.61
P/C
-
P/FCF
34.72
Quick Ratio
2.17
Current Ratio
3.9
Debt / Equity
0.05
LT Debt / Equity
0.01
-
-
EPS (TTM)
52.11
EPS next Y
84.9
EPS next Q
-
EPS this Y
7.05%
EPS next Y
62.92%
EPS next 5Y
76.29%
EPS last 5Y
6.76%
Revenue last 5Y
6.54%
Revenue Q/Q
0.99%
EPS Q/Q
-
-
-
-
-
SMA20
-5.79%
SMA50
-9.51%
SMA100
-19.76%
Inst Own
-
Inst Trans
-
ROA
11%
ROE
14%
ROC
0.17%
Gross Margin
39%
Oper. Margin
13%
Profit Margin
10%
Payout
-
Shs Outstand
46.26B
Shs Float
18.96B
-
-
-
-
Target Price
-
52W Range
1550.0-2360.0
52W High
-32.2%
52W Low
+3.23%
RSI
41.05
Rel Volume
0.35
Avg Volume
29.55M
Volume
10.28M
Perf Week
-1.54%
Perf Month
-11.36%
Perf Quarter
-21.57%
Perf Half Y
-24.17%
-
-
-
-
Beta
0.251
-
-
Volatility
18.65%, 72.05%
Prev Close
-0.31%
Price
1600
Change
-1.54%
KLBF.JK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 449.58 | 482.85 | 493.07 | 560.26 | 622.01 | |
Net income per share | 52.42 | 53.48 | 58.31 | 67.92 | 72.71 | |
Operating cash flow per share | 59.11 | 53.4 | 89.92 | 60.29 | 81.04 | |
Free cash flow per share | 29.82 | 11.09 | 66.06 | 38.94 | 62.33 | |
Cash per share | 71.08 | 69.04 | 115.12 | 138.14 | 88.04 | |
Book value per share | 311.97 | 339.05 | 371.32 | 417.71 | 438.24 | |
Tangible book value per share | 316.38 | 341.61 | 375.09 | 428.99 | 442.2 | |
Share holders equity per share | 311.97 | 339.05 | 371.32 | 417.71 | 438.24 | |
Interest debt per share | 8.04 | 18.09 | 26.32 | 14.33 | 25.99 | |
Market cap | 71250.19B | 75937.7B | 69374.46B | 75699.81B | 97218.32B | |
Enterprise value | 68454.27B | 73714.06B | 65324.34B | 70109.72B | 94436.26B | |
P/E ratio | 29 | 30.29 | 25.38 | 23.78 | 28.74 | |
Price to sales ratio | 3.38 | 3.36 | 3 | 2.88 | 3.36 | |
POCF ratio | 25.71 | 30.34 | 16.46 | 26.79 | 25.79 | |
PFCF ratio | 50.98 | 146.02 | 22.4 | 41.48 | 33.53 | |
P/B Ratio | 4.87 | 4.78 | 3.99 | 3.87 | 4.77 | |
PTB ratio | 4.87 | 4.78 | 3.99 | 3.87 | 4.77 | |
EV to sales | 3.25 | 3.26 | 2.83 | 2.67 | 3.26 | |
Enterprise value over EBITDA | 18.41 | 19.99 | 16.43 | 15.55 | 19.35 | |
EV to operating cash flow | 24.71 | 29.45 | 15.5 | 24.81 | 25.05 | |
EV to free cash flow | 48.97 | 141.75 | 21.1 | 38.41 | 32.57 | |
Earnings yield | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | |
Free cash flow yield | 0.02 | 0.01 | 0.04 | 0.02 | 0.03 | |
Debt to equity | 0.02 | 0.05 | 0.07 | 0.03 | 0.06 | |
Debt to assets | 0.02 | 0.04 | 0.05 | 0.02 | 0.04 | |
Net debt to EBITDA | -0.75 | -0.6 | -1.02 | -1.24 | -0.57 | |
Current ratio | 4.66 | 4.35 | 4.12 | 4.45 | 3.77 | |
Interest coverage | 167.49 | 110.04 | 47.96 | 91.47 | 108.97 | |
Income quality | 1.13 | 0 | 0 | 0 | 1.11 | |
Dividend Yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Payout ratio | 0.48 | 0.49 | 0.45 | 0.41 | 0.48 | |
Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Research and developement to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.05 | 0.06 | |
Capex to operating cash flow | -0.5 | -0.79 | -0.27 | -0.35 | -0.23 | |
Capex to revenue | -0.07 | -0.09 | -0.05 | -0.04 | -0.03 | |
Capex to depreciation | 0 | 0 | 0 | 0 | -2.25 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 606.58 | 638.72 | 697.97 | 798.97 | 846.73 | |
ROIC | 0.17 | 0.15 | 0.15 | 0.16 | 0.16 | |
Return on tangible assets | 0.14 | 0.13 | 0.12 | 0.13 | 0.13 | |
Graham Net | 107.99 | 100.07 | 126.53 | 164.19 | 141.98 | |
Working capital | 8362.12B | 8645.38B | 9898.61B | 12177.55B | 12279.19B | |
Tangible asset value | 14830.29B | 16013.13B | 17582.23B | 20108.07B | 20569.21B | |
Net current asset value | 7796.68B | 7663.35B | 8787.11B | 11311.45B | 11566.24B | |
Invested capital | 0.02 | 0.05 | 0.07 | 0.03 | 0.06 | |
Average receivables | 3623.27B | 3992.93B | 4112.01B | 4067.41B | 4811.75B | |
Average payables | 1199.22B | 1252.88B | 1228.12B | 1453.99B | 1832.11B | |
Average inventory | 3516.04B | 3606.28B | 3668.86B | 4343.52B | 6057.33B | |
Days sales outstanding | 65.69 | 67.62 | 63.65 | 57.04 | 69.63 | |
Days payables outstanding | 41.94 | 35.82 | 35.19 | 40.64 | 42.3 | |
Days of inventory on hand | 112.97 | 110.12 | 102.12 | 123.98 | 148.87 | |
Receivables turnover | 5.56 | 5.4 | 5.73 | 6.4 | 5.24 | |
Payables turnover | 8.7 | 10.19 | 10.37 | 8.98 | 8.63 | |
Inventory turnover | 3.23 | 3.31 | 3.57 | 2.94 | 2.45 | |
ROE | 0.17 | 0.16 | 0.16 | 0.16 | 0.17 | |
Capex per share | -29.29 | -42.3 | -23.86 | -21.35 | -18.71 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 313.59K | 166.65 | 169.17 | 157.15 | 0 | |
Net income per share | 36.42K | 19.28 | 18.4 | 14.47 | 0 | |
Operating cash flow per share | 40.29K | 21.9 | 18.4 | 7.23 | 0 | |
Free cash flow per share | 28.77K | 16.51 | 14.26 | 1.08 | 0 | |
Cash per share | 185.05K | 88.04 | 77.96 | 62.13 | 0 | |
Book value per share | 835.58K | 438.24 | 455.77 | 432.31 | 0 | |
Tangible book value per share | 855.83K | 442.2 | 459.79 | 432.5 | 0 | |
Share holders equity per share | 835.58K | 438.24 | 455.77 | 432.31 | 0 | |
Interest debt per share | 46.92K | 25.41 | 19.49 | 40.24 | 0 | |
Market cap | 42.64B | 97218.32B | 97683.48B | 95357.68B | 0 | |
Enterprise value | 3016.31B | 94436.26B | 95091.09B | 94461.03B | 1732.28B | |
P/E ratio | 0.01 | 27.1 | 28.54 | 35.41 | 0 | |
Price to sales ratio | 0.01 | 12.54 | 12.41 | 13.05 | 0 | |
POCF ratio | 0.05 | 95.43 | 114.15 | 283.73 | 0 | |
PFCF ratio | 0.06 | 126.57 | 147.32 | 1.9K | 0 | |
P/B Ratio | 0 | 4.77 | 4.61 | 4.74 | 0 | |
PTB ratio | 0 | 4.77 | 4.61 | 4.74 | 0 | |
EV to sales | -0.41 | 12.18 | 12.08 | 12.92 | -0.23 | |
Enterprise value over EBITDA | -2.52 | 69.07 | 76.53 | 105.89 | -2.12 | |
EV to operating cash flow | -3.21 | 92.7 | 111.12 | 281.06 | -1.84 | |
EV to free cash flow | -4.5 | 122.95 | 143.41 | 1.88K | -2.64 | |
Earnings yield | 19.9 | 0.01 | 0.01 | 0.01 | 0 | |
Free cash flow yield | 15.72 | 0.01 | 0.01 | 0 | 0 | |
Debt to equity | 0.06 | 0.06 | 0.04 | 0.09 | 0.05 | |
Debt to assets | 0.04 | 0.04 | 0.03 | 0.07 | 0.04 | |
Net debt to EBITDA | -2.56 | -2.03 | -2.09 | -1.01 | -2.12 | |
Current ratio | 3.8 | 3.77 | 3.81 | 3.35 | 3.9 | |
Interest coverage | 132.28 | 86.05 | 63.33 | 31.75 | 31.02 | |
Income quality | 1.11 | 1.14 | 1 | 0 | 0 | |
Dividend Yield | 1.81 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.09 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | |
Research and developement to revenue | 0.02 | -0.01 | 0.01 | 0.03 | 0.02 | |
Intangibles to total assets | 0.05 | 0.06 | 0.05 | 0.06 | 0.06 | |
Capex to operating cash flow | -0.29 | -0.25 | -0.23 | -0.85 | -0.3 | |
Capex to revenue | -0.04 | -0.03 | -0.02 | -0.04 | -0.04 | |
Capex to depreciation | -2.98 | -2.05 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 827.43K | 435.98 | 434.34 | 375.22 | 0 | |
ROIC | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | |
Return on tangible assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | |
Graham Net | 276.61K | 141.98 | 146.53 | 122.21 | 0 | |
Working capital | 11896.17B | 12279.19B | 12956.48B | 11679.2B | 12137.74B | |
Tangible asset value | 19942.46B | 20569.21B | 21387.38B | 20118.31B | 20692.85B | |
Net current asset value | 11111.1B | 11566.24B | 12249.53B | 11015.9B | 11508.35B | |
Invested capital | 0.06 | 0.06 | 0.04 | 0.09 | 0.05 | |
Average receivables | 5002.9B | 5327.17B | 5886.22B | 6282.25B | 6198.1B | |
Average payables | 1935.42B | 1981.89B | 2228.59B | 2272.16B | 1992.24B | |
Average inventory | 6332.61B | 6834.28B | 7331.81B | 7522.03B | 7298.95B | |
Days sales outstanding | 63.24 | 64.08 | 71.52 | 77.71 | 74.18 | |
Days payables outstanding | 40.51 | 37.58 | 47.62 | 43.08 | 36.78 | |
Days of inventory on hand | 136.75 | 132.25 | 147.8 | 153.14 | 139.14 | |
Receivables turnover | 1.42 | 1.4 | 1.26 | 1.16 | 1.21 | |
Payables turnover | 2.22 | 2.4 | 1.89 | 2.09 | 2.45 | |
Inventory turnover | 0.66 | 0.68 | 0.61 | 0.59 | 0.65 | |
ROE | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | |
Capex per share | -11.52K | -5.39 | -4.14 | -6.15 | 0 |
KLBF.JK Frequently Asked Questions
What is PT Kalbe Farma Tbk. stock symbol ?
PT Kalbe Farma Tbk. is a ID stock and trading under the symbol KLBF.JK
What is PT Kalbe Farma Tbk. stock quote today ?
PT Kalbe Farma Tbk. stock price is $1600 today.
Is PT Kalbe Farma Tbk. stock public?
Yes, PT Kalbe Farma Tbk. is a publicly traded company.